Commission issues guidance to mitigate clinical trial disruption in the EU

Commission has published guidance to ensure that clinical trials can continue taking place in the EU during the COVID-19 pandemic. The aim is to mitigate the disruption of clinical research in Europe and therefore the negative effects of the pandemic, without compromising on quality and safety. These recommendations are an important part of the overall strategy in finding treatments and a vaccine to protect citizens against the coronavirus.

source https://www.pharmatutor.org/pharma-news/2020/commission-issues-guidance-to-mitigate-clinical-trial-disruption-in-the-eu